Results 91 to 100 of about 35,947 (209)

Psoriasis Area and Severity Index (PASI) Objectivisation by Flow Cytometry Analysis of Major Lymphocytes Subsets. [PDF]

Acta Inform Med, 2023
Zecevic-Pasic L, Dzananovic N, Gojak R, Tihic-Kapidzic S, Hasanefendic B, Begovic E, Fazlagic A.   +6 more
europepmc   +1 more source

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial [PDF]

, 2014
Objective: Assess ustekinumab efficacy (week 24/week 52) and safety (week 16/week 24/week 60) in patients with active psoriatic arthritis (PsA) despite treatment with conventional and/or biological anti-tumour necrosis factor (TNF) agents. Methods: In
Alten, R., Birbara, C., Boh, E., Braun, J., Budd, J., Chattapadhyay, C., Chudzik, D., Claudepierre, P., Cooper, R., Dooley, L. T., Doyle, M. K., Drescher, E., Dutz, J., Edwards, C., El-Kadi, H., Elewski, B., Erlacher, L., Flipo, R., Fretzin, S., George, E., Gladstein, G., Gottlieb, A. B., Griffin, R., Grisanti, M., Guenther, L., Gulliver, W., Hobbs, K., Huang, E., Ilivanova, E., Jeka, S., Kavanaugh, A., Khraishi, M., Kokhan, M., Korman, N., Kunynetz, R., Leonardi, C., Lessard, C., Li, S., Lindquist, U., Martin, A., Matheson, R., McInnes, I.B., Mendelsohn, A. M., Murphy, F., Nasonov, E., Palmer, W., Papp, K., Perate, M., Puig, L., Rahman, P., Rech, J., Rell-Bakalarska, M., Rich, P., Ritchlin, C., Rosen, C., Rudin, A., Ruppert-Roth, A., Scheinecker, C., Seigel, S., Shaikh, S., Sheeran, T., Shen, Y.-K., Shergy, W., Siegel, E., Sierakowski, S., Sofen, H., Szanto, S., Tahir, H., Telegdy, E., Toth, D., Walker, D., Wang, Y., Whitman, M., Wilson, A., Witt, M., Wollenhaupt, J., Zoschke, D., Zubrzycka, A.   +77 more
core   +1 more source

Relationship between retinal sensitivity and disease activity in patients with psoriasis vulgaris

Clinics, 2015
OBJECTIVES: Psoriasis is a hyperproliferative chronic inflammatory skin disease of unknown etiology and ocular structures and visual pathways can also be affected during the course of this disease.
Helin Deniz Demir, Göknur Kalkan, Semiha Kurt, Alper Güneş, Engin Sezer, Ünal Erkorkmaz   +5 more
doaj   +1 more source

Sexual Dysfunctions in Psoriatic Patients [PDF]

, 2015
Psoriasis is a chronic, immune-mediated disorder with a worldwide occurrence characterized by well-defined infiltrated erythematous papules and plaques, covered by silvery white or yellowish scales.
Georgescu, Simona Roxana, Sarbu, Alexandra Elenda, Sarbu, Maria Isabela, Tampa, Mircea   +3 more
core   +2 more sources

Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study [PDF]

, 2017
Objectives. To assess long-term efficacy, safety and tolerability of secukinumab up to 104 weeks in patients with active PsA. Methods. Patients with PsA (n = 397) were randomized to s.c. secukinumab 300, 150 or 75 mg or placebo at baseline, weeks 1, 2,
Delicha, Eumorphia-Maria, Gottlieb, Alice B., Kajekar, Radhika, Kirkham, Bruce, McInnes, Iain B., Mease, Philip J., Mpofu, Shephard, Pricop, Luminita, Rahman, Proton, Ritchlin, Christopher T.   +9 more
core   +2 more sources

Bounded integer model-based analysis of psoriasis area and severity index in patients with moderate-to-severe plaque psoriasis receiving BI 730357. [PDF]

CPT Pharmacometrics Syst Pharmacol, 2023
Ooi QX, Kristoffersson A, Korell J, Flack M, L Plan E, Weber B.   +5 more
europepmc   +1 more source

Impairment of Sexual Life in 3,485 Dermatological Outpatients From a Multicentre Study in 13 European Countries [PDF]

, 2016
Skin conditions may have a strong impact on patients' sexual life, and thus influence personal relationships. Sexual issues are difficult to discuss directly in clinical practice, and a mediated instrument may be useful to capture such information.
Abeni, D., Altunay, I.K., Balieva, F., Dalgard, F., Evers, A.W.M., Finlay, A.Y., Gieler, U., Halvorsen, J.A., Jemec, G.B., Kupfer, J., Lien, L., Linder, M.D., Marron, S.E., Misery, L., Romanov, D.V., Salek, S.S., Sampogna, F., Szabo, C., Szepietowski, J.C., Titeca, G., Tomas-Aragones, L.   +20 more
core   +11 more sources

Reduction of 75% in the Psoriasis Area and Severity Index (PASI) for Moderate-to-Severe Psoriasis Vulgaris

Journal of Society Medicine
Introduction: Psoriasis vulgaris is a chronic inflammatory skin disorder characterized by the presence of scaly, red plaques. The severity of the condition is often evaluated using the Psoriasis Area and Severity Index (PASI), which quantifies the extent and severity of skin lesions.
Nahrisyah Nahrisyah, Kristo A. Nababan
openaire   +1 more source

Impact of psoriasis disease severity and special area involvement on patient-reported outcomes in the real world: an analysis from the CorEvitas psoriasis registry

Journal of Dermatological Treatment
Background The impact of psoriasis in special areas (i.e., scalp, nails, palms, soles, genitals) on patient physical functioning, health-related quality of life (HRQoL), and work abilities has not been fully characterized.
Bruce Strober, Kristina Callis Duffin, Mark Lebwohl, Adam Sima, Jud Janak, Manish Patel, Huzefa Photowala, Vishvas Garg, Jerry Bagel   +8 more
doaj   +1 more source

Role of Shear-Wave Elastography in Achilles Tendon in Psoriatic Arthritis and Its Correlation with Disease Severity Score, Psoriasis Area and Severity Index. [PDF]

Indian J Radiol Imaging, 2022
Saha D, Prakash M, Sinha A, Singh T, Dogra S, Sharma A.   +5 more
europepmc   +1 more source